Activation of AKT signaling promotes cell growth and survival in α7β1 integrin-mediated alleviation of muscular dystrophy

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1812, Issue 4, 2011, Pages 439-446

  Boppart, Marni D ^a   Burkin, Dean J ^c   Kaufman, Stephen J ^b  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^c UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

Author keywords

7 Integrin; AKT; Apoptosis; Cell signaling; Integrin linked kinase (ILK); Muscular dystrophy

Indexed keywords

ALPHA7 INTEGRIN; ALPHA7BETA1 INTEGRIN; INTEGRIN; INTEGRIN LINKED KINASE; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BAD; PROTEIN KINASE B; S6 KINASE; SERINE DERIVATIVE; SYNAPTOPHYSIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL GROWTH; CELL SURVIVAL; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE OVEREXPRESSION; IN VITRO STUDY; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; WILD TYPE;

ANIMALS; APOPTOSIS; GENE EXPRESSION REGULATION; INTEGRINS; MICE; MICE, INBRED MDX; MICE, TRANSGENIC; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; SIGNAL TRANSDUCTION;

MUS;

EID: 78951472318     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2011.01.002     Document Type: Article

References (55)

1. Monaco A.P., Neve R.L., Colletti-Feener C., Bertelson C.J., Kurnit D.M., Kunkel L.M. Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene. Nature 1986, 323:646-650.
2. Sicinski P., Geng Y., Tyder-Cook A.S., Barnard E.A., Darlison M.G., Barnard P.J. The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science 1989, 244:1578-1580.
3. Matsumura K., Campbell K.P. Dystrophin-glycoprotein complex: its role in the molecular pathogenesis of muscular dystrophies. Muscle Nerve 1994, 17:2-15.
4. Campbell K.P. Three muscular dystrophies: loss of cytoskeleton-extracellular matrix linkage. Cell 1995, 80:675-679.
5. Rybakova I.N., Amann K.J., Ervasti J.M. A new model for the interaction of dystorphin with F-actin. J. Cell Biol. 1996, 135:661-672.
6. Bulfield G., Siller W.G., Wight P.A., Moore K.J. X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc. Natl Acad. Sci. USA 1984, 81:1189-1192.
7. Matsumura K., Ervasti J.M., Ohlendieck K., Kahl S.D., Campbell K.P. Association of dystrophin-related protein with dystrophin-associated proteins in mdx mouse muscle. Nature 1992, 360:588-591.
8. Deconinck A.E., Potter A.C., Tinsley J.M., Wood S.J., Vater R., Young C., Metzinger L., Vincent A., Slater C.R., Davies K.E. Utrophin-dystrophin deficient mice as a model for Duchenne muscular dystrophy. Cell 1997, 90:717-727.
9. Grady R.M., Teng H., Nichol M.C., Cunningham J.C., Wilkinson R.W., Sanes J.R. Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy. Cell 1997, 90:729-738.
10. Hodges B.L., Hayashi Y.K., Nonaka I., Wang W., Arahata K., Kaufman S.J. Altered expression of the α7β1 integrin in human and murine muscular dystrophies. J. Cell Sci. 1997, 110:2873-2881.
11. Burkin D.J., Wallace G.Q., Nichol K.J., Kaufman D.J., Kaufman S.J. Enhanced expression of the α7β1 integrin reduces muscular dystrophy and restores viability in dystrophic mice. J. Cell Biol. 2001, 152:1207-1218.
12. Liu J., Burkin D.J., Kaufman S.J. Increasing α7β1-integrin promotes muscle cell proliferation, adhesion, and resistance to apoptosis without changing gene expression. Am. J. Physiol. Cell Physiol. 2008, 294:C627-C640.
13. Gurpur P., Liu J., Burkin D.J., Kaufman S.J. Valproic acid activates the PI3K/Akt/mTOR pathway in muscle and ameliorates pathology in a mouse model of Duchenne muscular dystrophy. Am. J. Pathol. 2009, 174:999-1008.
14. Tidball J.G., Albrecht D.E., Lokensgard B.E., Spencer M.J. Apoptosis precedes necrosis of dystrophin-deficient mice. J. Cell Sci. 1995, 108:2197-2204.
15. Wang H., Chang L., Brixius K., Wickstrom S.A., Montanez E., Thievessen I., Schwander M., Muller U., Bloch W., Mayer U., Fassler R. Integrin-linked kinase stabilizes myotendinous junctions and protects muscle from stress-induced damage. J. Cell Biol. 2008, 180:1037-1049.
16. Bendig G., Grimmler M., Huttner I.G., Wessels G., Dahme T., Just S., Trano N., Katus H.A., Fishman M.C., Rottbauer W. Integrin-linked kinase, a novel component of the cardiac mechanical stretch sensor, controls contractility in the zebrafish heart. Genes Dev. 2006, 20:2361-2372.
17. White D.E., Coutu P., Shi Y.F., Tardif J.C., Nattel S., St Arnaud R., Dedhar S., Muller W.J. Targeted ablation of ILK from the murine heart results in dilated cardiomyopathy and spontaneous heart failure. Genes Dev. 2006, 20:2355-2360.
18. Song W.K., Wang W., Foster R.F., Bielser D.A., Kaufman S.J. H36-α7 is a novel integrin alpha chain that is developmentally regulated during skeletal myogenesis. J. Cell Biol. 1992, 117:643-667.
19. Burkin D.J., Gu M., Hodges B.L., Campanelli J.T., Kaufman S.J. A functional role for specific spliced variants of the alpha7 beta1 integrin in acetylcholine receptor clustering. J. Cell Biol. 1998, 143:1067-1075.
20. Song W.K., Wang W., Sato H., Bielser D.A., Kaufman S.J. Expression of α7 integrin cytoplasmic domains during skeletal muscle development: alternate forms, conformational change, and homologies with serine/threonine kinases and tyrosine phosphatases. J. Cell Sci. 1993, 106:1139-1152.
21. Hynes R.O. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 1992, 69:11-25.
22. Dedhar S. Cell-substrate interactions and signaling through ILK. Curr. Opin. Cell Biol. 2000, 12:250-256.
23. Wu C., Dedhar S. Integrin-linked kinase (ILK) and its interactors: a new paradigm for the coupling of extracellular matrix to actin cytoskeleton ad signaling complexes. J. Cell Biol. 2001, 155:505-510.
24. Delcommenne M., Tan C., Gray V., Rue L., Woodgett J., Dedhar S. Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B-AKT by the integrin-linked kinase. Proc. Natl Acad. Sci. USA 1998, 95:11211-11216.
25. Langenbach K.J., Rando T.A. Inhibition of dystroglycan binding to laminin disrupts the PI3K/AKT pathway and survival signaling in muscle cells. Muscle Nerve 2002, 26:644-653.
26. Chiang C.W., Kanies C., Kim K.W., Fang W.B., Parkhurst C., Xie M., Henry T., Yang E. Protein phosphatase 2A dephosphorylation of phosphoserine 112 plays the gatekeeper role for BAD-mediated apoptosis. Mol. Cell. Biol. 2003, 23:6350-6362.
27. Bodine S.C., Stitt T.N., Gonzalez M., Kline W.O., Stover G.L., Bauerlein R., Zlotchenko E., Scrimgeour A., Lawrence J.C., Glass D.J., Yancopoulos G.D. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat. Cell Biol. 2001, 3:1014-1019.
28. Burkin D.J., Wallace G.Q., Milner D.J., Chaney E.J., Mulligan J.A., Kaufman S.J. Transgenic expression of α7β1 integrin maintains muscle integrity, increases regenerative capacity, promotes hypertrophy, and reduces cardiomyopathy in dystrophic mice. Am. J. Pathol. 2005, 166:253-263.
29. Lang J.M., Esser K.A., Dupont-Versteegden E.E. Altered activity of signaling pathways in diaphragm and tibialis anterior muscle of dystrophic mice. Exp. Biol. Med. (Maywood) 2004, 229:503-511.
30. Incitti T., De Angelis F.G., Cazzella V., Sthandier O., Pinnaro C., Legnini I., Bozzoni I. Exon skipping and Duchenne muscular dystrophy therapy: selection of the most active U1 snRNA antisense able to induce dystrophin exon 51 skipping. Mol. Ther. 2010, 18:1675-1682.
31. Koppanati B.M., Li J., Wang B., Daood M., Zheng H., Xiao X., Watchko J.F., Clemens P.R. Improvement of the mdx mouse dystrophic phenotype by systemic in utero AAV8 delivery of a minidystrophin gene. Gene Ther. 2010, 17:1355-1362.
32. Odom G.L., Banks G.B., Shultz B.R., Gregorevic P., Chamberlain J.S. Preclinical studies for gene therapy of Duchenne muscular dystrophy. J. Child Neurol. 2010, 25:1149-1157.
33. Odom G.L., Gregorevic P., Allen J.M., Finn E., Chamberlain J.S. Microutrophin delivery through rAAV6 increases lifespan and improves muscle function in dystrophic dystrophin/utrophin deficient mice. Mol. Ther. 2008, 16:1539-1545.
34. Paul A.C., Sheard P.W., Kaufman S.J., Duxson M.J. Localization of alpha 7 integrins and dystrophin suggest potential for both lateral and longitudinal transmission of tension in large mammalian muscles. Cell Tissue Res. 2002, 308:255-265.
35. Persad S., Attwell S., Gray V., Mawji N., Deng J.T., Leung D., Yan J., Sanghera J., Walsh M.P., Dedhar S. Regulation of protein kinase B/Akt-Serine 473 phosphorylation by integrin-linked kinase. J. Biol. Chem. 2001, 276:27462-27469.
36. Troussard A.A., Mawji N.M., Ong C., Mui A., St Arnaud R., Dedhar S. Conditional knock-out of integrin-linked kinase (ILK) demonstrates an essential role in PKB/Akt activation. J. Biol. Chem. 2003, 278:22374-22378.
37. Mayer U., Saher G., Fassler R., Bornemann A., Echtermeyer F., von der Mark H., Miosge N., Poschl E., von der Mark K. Absence of integrin alpha 7 causes a novel form of muscular dystrophy. Nat. Genet. 1997, 17:318-323.
38. Rooney J.E., Welser J.V., Dechert M.A., Flintoff-Dye N.L., Kaufman S.J., Burkin D.J. Severe muscular dystrophy in mice that lack dystrophin and alpha7 integrin. J. Cell Sci. 2006, 119:2185-2195.
39. Vachon P.H., Xu H., Liu L., Loechel F., Hayashi Y., Arahata K., Reed J.C., Wewer U.M., Engvall E. Integrins (alpha7beta1) in muscle function and survival. Disrupted expression in merosin-deficient congenital muscular dystrophy. J. Clin. Invest. 1997, 100:1870-1881.
40. Alejandro E.U., Johnson J.D. Inhibitin of Raf-1 alters multiple downstream pathways to induce pancreatic beta-cell apoptosis. J. Biol. Chem. 2008, 283:2407-2417.
41. Mabuchi S., Ohmichi M., Kimura A., Hisamoto K., Hayakawa J., Nishio Y., Adachi K., Takahashi K., Arimoto-Ishida E., Nakatsuji Y., Tasaka K., Murata Y. Inhibition of phosphorylation of BAD and Raf-1 by Akt sensitizes human ovarian cancer cells to paclitaxel. J. Biol. Chem. 2002, 227:33490-33500.
42. Dogra C., Changotra H., Wergedal J.E., Kumar A. Regulation of phosphatidylinositol 3-kinase (PI3K)/Akt and nuclear factor-kappa B signaling pathways in dystrophin-deficient skeletal muscle in response to mechanical stretch. J. Cell. Physiol. 2006, 208:575-585.
43. Peter A.K., Crosbie R.H. Hypertrophic response of Duchenne and limb-girdle muscular dystrophies is associated with activation of Akt pathway. Exp. Cell Res. 2006, 312:2580-2591.
44. Xiong Y., Zhou Y., Jarrett H.W. Dystrophin glycoprotein complex-associated Gbetagamma subunits activate phosphatidylinositol-3-kinase/Akt signaling in skeletal muscle in a laminin-dependent manner. J. Cell. Physiol. 2009, 219:402-414.
45. Peter A.K., Ko C.Y., Kim M.H., Hsu N., Ouchi N., Rhie S., Izumiya Y., Zeng L., Walsh K., Crosbie R.H. Myogenic Akt signaling upregulates the utrophin-glycoprotein complex and promotes sarcolemma stability in muscular dystrophy. Hum. Mol. Genet. 2009, 18:318-327.
46. Vandenburgh H., Kaufman S. In vitro model for stretch-induced hypertrophy of skeletal muscle. Science 1979, 203:265-268.
47. Raingeaud J., Gupta S., Rogers J.S., Dickens M., Han J., Ulevitch R.J., Davis R.J. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J. Biol. Chem. 1995, 270:7420-7426.
48. Boppart M.D., Hirshman M.F., Sakamoto K., Fielding R.A., Goodyear L.J. Static stretch increases c-Jun NH2-terminal kinase activity and p38 phosphorylation in rat skeletal muscle. Am. J. Physiol. Cell Physiol. 2001, 280:C352-C358.
49. Zetser A., Gredinger E., Bengal E. p38 mitogen-activated protein kinase pathway promotes skeletal muscle differentiation. Participation of the Mef2c transcription factor. J. Biol. Chem. 1999, 274:5193-5200.
50. Akimoto T., Pohnert S.C., Li P., Zhang M., Gumbs C., Rosenberg P.B., Williams R.S., Yan Z. Exercise stimulates Pgc-1alpha transcription in skeletal muscle through activation of the p38 MAPK pathway. J. Biol. Chem. 2005, 280:19587-19593.
51. Pogozelski A.R., Geng T., Li P., Yin X., Lira V.A., Zhang M., Chi J.T., Yan Z. p38gamma mitogen-activated protein kinase in as key regulator in skeletal muscle metabolic adaptation in mice. PLoS ONE 2009, 4:e7934.
52. Kim M.J., Choi S.Y., Park I.C., Hwang S.G., Kim C., Choi Y.H., Kim H., Lee K.H., Lee S.J. Opposing roles of c-Jun NH2-terminal kinase and p38 mitogen-activated protein kinase in the cellular response to ionizing radiation in human cervical cancer cells. Mol. Cancer Res. 2008, 6:1718-1731.
53. Hnia K., Hugon G., Rivier F., Masmoudi A., Mercier J., Mornet D. Modulation of p38 mitogen-activated protein kinase cascade and metalloproteinase activity in diaphragm muscle in response to free radical scavenger administration in dystrophin-deficient mdx mice. Am. J. Pathol. 2007, 170:633-643.
54. Feron M., Guevel L., Rouger K., Dubreil L., Arnaud M.-C., Ledevin M., Megeney L.A., Cherel Y., Sakanyan V. PTEN contributes to profound PI3K/Akt signaling pathway deregulation in dystrophin-deficient dog muscle. Am. J. Pathol. 2009, 174:1459-1470.
55. Boppart M.D., Burkin D.J., Kaufman S.J. α7β1-Integrin regulates mechanotransduction and prevents skeletal muscle injury. Am. J. Physiol. Cell Physiol. 2006, 290:1660-1665.